Thrombin generation and heparin-induced thrombocytopenia

Area of Science:

• Hematology
• Immunology
• Thrombosis Research

Background:

• Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy.
• HIT involves IgG antibodies against the platelet factor 4-heparin complex, leading to platelet activation and procoagulant microparticle generation.

Purpose of the Study:

• To evaluate the thrombin generation assay's ability to detect procoagulant activity in HIT patients.
• To determine if patient platelet-poor plasma (PPP) can induce procoagulant activity in donor platelet-rich plasma (PRP).

Main Methods:

• Two patient groups were studied: 23 with HIT and 25 without.
• Mixtures of donor PRP and patient PPP were incubated with heparin or saline.
• Thrombin generation was measured using calibrated thrombinography, analyzing heparin's effect via wH/woH ratios.

Main Results:

• HIT patient plasma (group 1) induced procoagulant activity in donor platelets with low heparin concentrations.
• A 'HIT thrombogram profile' (three specific ratio cut-offs) identified these patients.
• Thrombinography results correlated well with platelet aggregation tests.

Conclusions:

• The study highlights the paradox of enhanced thrombin generation in HIT patients when exposed to heparin.
• The defined HIT thrombogram profile effectively detects the procoagulant activity of HIT IgG antibodies.